Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle.

A new acoustically-active delivery vehicle was developed by conjugating liposomes and microbubbles, using the high affinity interaction between avidin and biotin. Binding between microbubbles and liposomes, each containing 5% DSPE-PEG2kBiotin, was highly dependent on avidin concentration and observed above an avidin concentration of 10 nM. With an optimized avidin and liposome concentration, we measured and calculated as high as 1000 to 10,000 liposomes with average diameters of 200 and 100 nm, respectively, attached to each microbubble. Replacing avidin with neutravidin resulted in 3-fold higher binding, approaching the calculated saturation level. High-speed photography of this new drug delivery vehicle demonstrated that the liposome-bearing microbubbles oscillate in response to an acoustic pulse in a manner similar to microbubble contrast agents. Additionally, microbubbles carrying liposomes could be spatially concentrated on a monolayer of PC-3 cells at the focal point of ultrasound beam. As a result of cell-vehicle contact, the liposomes fused with the cells and internalization of NBD-cholesterol occurred shortly after incubation at 37 degrees C, with internalization of NBD-cholesterol substantially enhanced in the acoustic focus.

[1]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[2]  Susannah H Bloch,et al.  Radiation-Force Assisted Targeting Facilitates Ultrasonic Molecular Imaging , 2004, Molecular imaging.

[3]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[4]  S. Kaul,et al.  Relation between air-filled albumin microbubble and red blood cell rheology in the human myocardium. Influence of echocardiographic systems and chest wall attenuation. , 1996, Circulation.

[5]  D. Sahn,et al.  Phase I clinical trials of MRX-115. A new ultrasound contrast agent. , 1997, Investigative radiology.

[6]  S. Stewart,et al.  Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Boxer,et al.  General method for modification of liposomes for encoded assembly on supported bilayers. , 2005, Journal of the American Chemical Society.

[8]  Paul A Dayton,et al.  The magnitude of radiation force on ultrasound contrast agents. , 2002, The Journal of the Acoustical Society of America.

[9]  P. Balgavý,et al.  Determination of bilayer thickness and lipid surface area in unilamellar dimyristoylphosphatidylcholine vesicles from small-angle neutron scattering curves: a comparison of evaluation methods , 2004, European Biophysics Journal.

[10]  Xin Yu Wang,et al.  Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Jonathan R. Lindner,et al.  Molecular and Cellular Imaging with Targeted Contrast Ultrasound , 2005, Proceedings of the IEEE.

[12]  J. Heyes,et al.  Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Paul A Dayton,et al.  Lateral phase separation in lipid-coated microbubbles. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[14]  P. Dayton,et al.  A method for radiation-force localized drug delivery using gas-filled lipospheres , 2004, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[15]  J. Mason,et al.  Geometric packing constraints in egg phosphatidylcholine vesicles. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Unger,et al.  Therapeutic applications of lipid-coated microbubbles. , 2004, Advanced drug delivery reviews.

[17]  Paul A Dayton,et al.  Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[18]  F. Bates,et al.  Polymer vesicles in vivo: correlations with PEG molecular weight. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[19]  N. Zaffaroni,et al.  Tethering functional ligands onto shell of ultrasound active polymeric microbubbles. , 2006, Biomacromolecules.

[20]  Jonathan R. Lindner,et al.  Microbubbles in medical imaging: current applications and future directions , 2004, Nature Reviews Drug Discovery.

[21]  N. Düzgüneş,et al.  Fusogenic capacities of divalent cations and effect of liposome size. , 1985, Biochemistry.

[22]  Raffi Bekeredjian,et al.  Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. , 2005, Ultrasound in medicine & biology.

[23]  P. Dayton,et al.  Threshold of fragmentation for ultrasonic contrast agents. , 2001, Journal of biomedical optics.

[24]  Sheila Podell,et al.  Physical and biochemical stability of Optison®, an injectable ultrasound contrast agent , 1999, Biotechnology and applied biochemistry.

[25]  S. Kaul,et al.  Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression , 2005, Circulation.

[26]  Paul A Dayton,et al.  Targeted imaging using ultrasound , 2002, Journal of magnetic resonance imaging : JMRI.

[27]  H. Jablonowski,et al.  Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group. , 1996, British Journal of Cancer.

[28]  A. Klibanov,et al.  Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. , 2005, Bioconjugate chemistry.

[29]  J. Hossack,et al.  Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification , 2005, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[30]  F. Berr,et al.  A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  Raffi Bekeredjian,et al.  Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Z. Török,et al.  Phospholipid vesicles increase the survival of freeze-dried human red blood cells. , 2005, Cryobiology.

[33]  Alexander L. Klibanov,et al.  Microbubble Contrast Agents: Targeted Ultrasound Imaging and Ultrasound-Assisted Drug-Delivery Applications , 2006, Investigative radiology.

[34]  M. Wilchek,et al.  The use of the avidin-biotin complex as a tool in molecular biology. , 2006, Methods of biochemical analysis.

[35]  Shuliang Li,et al.  Liposome-encapsulated actin-hemoglobin (LEAcHb) artificial blood substitutes. , 2005, Biomaterials.

[36]  M. Bally,et al.  Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia , 2004, Cancer Chemotherapy and Pharmacology.

[37]  K. Edwards,et al.  Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids. , 2003, Biophysical journal.

[38]  M. Bally,et al.  Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. , 1995, British Journal of Cancer.

[39]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Bally,et al.  Encapsulation of Vincristine in Liposomes Reduces its Toxicity and Improves its Anti-Tumor Efficacy , 1995 .

[41]  P. Dayton,et al.  Targeted imaging using ultrasound contrast agents , 2004, IEEE Engineering in Medicine and Biology Magazine.